DE602005015329D1 - Rutheniumkomplexe zur krebsbehandlung - Google Patents

Rutheniumkomplexe zur krebsbehandlung

Info

Publication number
DE602005015329D1
DE602005015329D1 DE602005015329T DE602005015329T DE602005015329D1 DE 602005015329 D1 DE602005015329 D1 DE 602005015329D1 DE 602005015329 T DE602005015329 T DE 602005015329T DE 602005015329 T DE602005015329 T DE 602005015329T DE 602005015329 D1 DE602005015329 D1 DE 602005015329D1
Authority
DE
Germany
Prior art keywords
cancer treatment
ruthenium compositions
ruthenium
compositions
ruthenium compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005015329T
Other languages
English (en)
Inventor
Michel Pfeffer
Claude Sirlin
Jean-Philippe Loeffler
Christian Gaiddon
Pierre Bischoff
Pierre Jeannequin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Strasbourg
Original Assignee
Universite de Strasbourg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Strasbourg filed Critical Universite de Strasbourg
Publication of DE602005015329D1 publication Critical patent/DE602005015329D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00—Metallocenes
    • C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE602005015329T 2004-07-13 2005-07-13 Rutheniumkomplexe zur krebsbehandlung Active DE602005015329D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0407819A FR2873037B1 (fr) 2004-07-13 2004-07-13 Methodes et compositions pour le traitement de cancers
PCT/FR2005/001814 WO2006016069A1 (fr) 2004-07-13 2005-07-13 Methodes et compositions pour le traitement de cancers

Publications (1)

Publication Number Publication Date
DE602005015329D1 true DE602005015329D1 (de) 2009-08-20

Family

ID=34946740

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005015329T Active DE602005015329D1 (de) 2004-07-13 2005-07-13 Rutheniumkomplexe zur krebsbehandlung

Country Status (8)

Country Link
US (1) US8193175B2 (de)
EP (1) EP1776103B1 (de)
AT (1) ATE435647T1 (de)
DE (1) DE602005015329D1 (de)
ES (1) ES2329697T3 (de)
FR (1) FR2873037B1 (de)
PL (1) PL1776103T3 (de)
WO (1) WO2006016069A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2947180A1 (fr) * 2009-06-29 2010-12-31 Univ Strasbourg Methodes et compositions pour le traitement de cancers
CA2818163A1 (en) * 2010-11-17 2012-05-24 Niiki Pharma Inc. Method of treating hematological cancers
GB201116057D0 (en) 2011-09-16 2011-11-02 Univ York Synthesis and anticancer activity of ruthenium (II) cis-cis-1,3,5-triaminocyclohexane complexes
ES2452719B1 (es) * 2012-10-01 2015-01-26 Universitat De Barcelona Compuestos antitumorales de rutenio (II)
CN116178456A (zh) 2014-06-11 2023-05-30 德克萨斯州大学***董事会 用于克服铂耐受性的德克萨卟啉-pt(iv)缀合物及组合物
WO2020138570A1 (ko) * 2018-12-28 2020-07-02 서울대학교 산학협력단 신규 루테늄 착화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19612291A1 (de) * 1996-03-28 1997-10-02 Bernhard K Prof Dr Dr Keppler Arzneimittelzubereitungen enthaltend tumorhemmend wirkende Ruthenium(III)-Komplexe
BR0011678A (pt) * 1999-03-19 2002-02-26 Anormed Inc Composições farmacêuticas compreendendo complexos de metal

Also Published As

Publication number Publication date
ES2329697T3 (es) 2009-11-30
FR2873037A1 (fr) 2006-01-20
EP1776103A1 (de) 2007-04-25
EP1776103B1 (de) 2009-07-08
FR2873037B1 (fr) 2008-04-11
WO2006016069A1 (fr) 2006-02-16
US8193175B2 (en) 2012-06-05
US20080051370A1 (en) 2008-02-28
PL1776103T3 (pl) 2009-12-31
ATE435647T1 (de) 2009-07-15

Similar Documents

Publication Publication Date Title
IL258880A (en) Compounds of diarylhydantoin
MX2007011545A (es) Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr.
SG164368A1 (en) Treatment of cancer
IL184617A0 (en) Dr5 antibodies and uses thereof
TW200716141A (en) Compositions and methods for treatment for neoplasms
BRPI0611670A2 (pt) método para o tratamento ou prevenção de câncer em um indivíduo
SG160412A1 (en) Anti-igfr1 antibody therapeutic combinations
WO2006107451A3 (en) Honokiol derivatives for the treatment of proliferative disorders
BRPI0513310A (pt) análogos de tetrapeptìdeo
WO2007061874A3 (en) Methods and compositions for use in treating cancer
WO2007053573A3 (en) Treatment of cancer with sorafenib
WO2006113483A3 (en) Methods and compositions for treating or preventing cancer
TW200716088A (en) Formulations and methods for treating amyloidosis
WO2005085188A3 (en) Compounds and methods for anti-tumor therapy
WO2007033167A3 (en) Compositions and methods for detecting and treating cancer
WO2009009034A3 (en) Methods and compositions useful in the treatment of mucositis
DE602005015329D1 (de) Rutheniumkomplexe zur krebsbehandlung
EA200971067A1 (ru) Триазолиламинопиримидиновые соединения
EP2099458A4 (de) Verbindungen und verfahren zur enzym-vermittelten tumordarstellung und therapie
TW200738236A (en) Certain chemical entities, compositions, and methods
WO2007047803A3 (en) Use of prolactin in the prophylactic treatment of cancer
MXPA05009428A (es) Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.
TW200714284A (en) Novel method
TW200640948A (en) DR5 antibodies and uses thereof
UA101379C2 (en) Amidophenoxyindazoles useful in the treatment of cancer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition